AI-generated summary
The authors conducted a literature review of photobiomodulation in patients with central nervous system diseases, searching four databases and analyzing 95 papers. They report that the evidence is preliminary and that larger studies with adequate sample sizes are needed to optimize treatment parameters.
- Studies included
- 95
- Who or what was studied
- Patients with central nervous system diseases, including stroke, traumatic brain injury, Parkinson's disease, Alzheimer's disease, and major depressive disorder
- Limits stated in the abstract
- The abstract states that evidence is preliminary and additional studies with adequate sample size are needed to optimize treatment parameters.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on ovid.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Traumatic brain injury, Near-infrared, Wound healing, Brain injury, Sample size, Stroke. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.